Center for Health + Technology (CHeT)
Center for Health + Technology (CHeT)
Advancing research and driving innovation.
The Center for Health + Technology is comprised of six units that contribute to the development of new therapeutics, diagnostics, and devices. We work collaboratively to advance innovation at multiple stages of diagnosis, drug development, and clinical care.
For more than three decades, CHeT has served as a worldwide leader in the conduct, planning, implementation, and analysis of large multi-center clinical research studies.
Our collaborators span the globe and include the National Institutes of Health, leading academic institutions, not-for-profit foundations, national advocacy groups, and industry innovators in pharma and technology.
155+
Clinical Studies
45K+
Research Participants
What We Do at CHeT
Translating Science into Hope: The CHeT Model for Neurological Drug Discovery
Over nearly four decades, CHeT has played an instrumental role in bringing 12 drugs and devices to market—including landmark treatments for Parkinson’s, Huntington’s, and neuromuscular diseases—while pioneering new ways to design, measure, and deliver clinical trials.
1997-2023: 12 FDA Approvals
Over the past 30+ years, CHeT has supported clinical studies that have led to 12 FDA Approvals, 10 through our Clinical Trials Coordination Center (CTCC), and 3 through our Clinical Materials Services Unit (CMSU), of which one is supported by both CTCC and CMSU.